Showing results (61-70 of 247) with videos related to
Sort By:
Pageof 25
World Journal of Gastrointestinal Oncology|December 2, 2021
New drugs for the treatment of metastatic colorectal cancerSara Cherri, Michela Libertini, Alberto ZaniboniCancers|May 20, 2020
Biliary Tract Cancer: Current Medical Treatment StrategiesEster Oneda, Mohammed Abu Hilal, Alberto ZaniboniThe Lancet. Oncology|March 2, 2005
Chemotherapy and anaesthetic drugs: too little is knownAlberto Zaniboni, Swapna Prabhu, Riccardo A AudisioJournal of Chemotherapy (Florence, Italy)|August 7, 2014
Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and managementFrancesca Aroldi, Tiziana Prochilo, Paola Bertocchi, et al.Journal of Gastrointestinal Oncology|August 2, 2014
Gastric cancer: toward a cisplatin-free disease?Fausto Petrelli, Sandro Barni, Stefano Cascinu, et al.Clinical Nuclear Medicine|March 30, 2021
Delayed PET/CT of Pericardial Synovial SarcomaAntonella Stefanelli, Giordano Savelli, Mattia Bonacina, et al.Clinical Colorectal Cancer|July 20, 2016
TAS-102 (Lonsurf) for the Treatment of Metastatic Colorectal Cancer. A Concise ReviewAlberto Zaniboni, Paola Bertocchi, Sandro Barni, et al.International Journal of Cancer|June 7, 2018
Noninferiority of three months versus six months of oxaliplatin-based adjuvant chemotherapy for resected colon cancer. How should IDEA findings affect clinical practice?Vincenzo Formica, Alberto Zaniboni, Fotios Loupakis, et al.Current Drug Safety|August 10, 2012
Oxaliplatin-induced lung toxicity. Case report and review of the literatureTiziana Prochilo, Chiara Abeni, Paola Bertocchi, et al.BMC Cancer|July 6, 2016
TAS-102, the first "cardio-gentle" fluoropyrimidine in the colorectal cancer landscape?Fausto Petrelli, Sandro Barni, Paola Bertocchi, et al.Pageof 25